Zhengye Biotechnology Holding annual ebitda
2024
2025
Zhengye Biotechnology Holding EBITDA Growth & History (ZYBT)
Zhengye Biotechnology Holding's calculated EBITDA was −$6.4M for fiscal 2025.
View full Zhengye Biotechnology Holding company overviewZhengye Biotechnology Holding annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.4M | −$11.9M | — |
| 2024 | 2024-12-31 | $5.6M | — | — |
Zhengye Biotechnology Holding ebitda trends
Between the periods ended 2024-12-31 and 2025-12-31, Zhengye Biotechnology Holding's ebitda decreased from $5.6M to −$6.4M, a change of −$11.9M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zhengye Biotechnology Holding source filings ↗